Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation

European Respiratory Journal

Volumn 41, Issue 2, 2013, Pages 396-401

  Finigan, James H ^a,b   Mishra, Rangnath ^a   Vasu, Vihas T ^a   Silveira, Lori J ^a   Nethery, David E ^c   Standiford, Theodore J ^d   Burnham, Ellen L ^b   Moss, Marc ^b   Kern, Jeffrey A ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Acute respiratory failure; Alveolar epithelium; Biomarkers; Inflammatory mediators

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEU DIFFERENTIATION FACTOR; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTRACHEAL INTUBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG LAVAGE; MALE; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGNAL TRANSDUCTION;

ACUTE LUNG INJURY; ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; EPITHELIUM; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; LUNG; MALE; MIDDLE AGED; NEUREGULIN-1; PULMONARY ALVEOLI; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTOR, ERBB-2; RESPIRATION, ARTIFICIAL;

EID: 84873392452     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00004912     Document Type: Article

References (35)

1. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-1693.
2. Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977; 116: 589-615.
3. Bachofen M, Weibel ER. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 1982; 3: 35-56.
4. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
5. Matthay MA. Function of the alveolar epithelial barrier under pathologic conditions. Chest 1994; 105: 67S-74S.
6. Inoue S, Michel RP, Hogg JC. Zonulae occludentes in alveolar epithelium and capillary endothelium of dog lungs studies with the freeze-fracture technique. J Ultrastruct Res 1976; 56: 215-225.
7. Gorin AB, Stewart PA. Differential permeability of endothelial and epithelial barriers to albumin flux. J Appl Physiol 1979; 47: 1315-1324.
8. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2: 127-137.
9. Kern JA, Robinson RA, Gazdar A, et al. Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines. Am J Respir Cell Mol Biol 1992; 6: 359-363.
10. Finigan JH, Faress JA, Wilkinson E, et al. Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury. J Biol Chem 2011; 286: 10660-10670.
11. Patel NV, Acarregui MJ, Snyder JM, et al. Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. Am J Respir Cell Mol Biol 2000; 22: 432-440.
12. Holmes WE, Sliwkowski MX, Akita RW, et al. Identification of heregulin, a specific activator of p185erbB2. Science 1992; 256: 1205-1210.
13. Vermeer PD, Einwalter LA, Moninger TO, et al. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 2003; 422: 322-326.
14. Gollamudi M, Nethery D, Liu J, et al. Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines. Lung Cancer 2004; 43: 135-143.
15. Nethery DE, Moore BB, Minowada G, et al. Expression of mutant human epidermal receptor 3 attenuates lung fibrosis and improves survival in mice. J Appl Physiol 2005; 99: 298-307.
16. Faress JA, Nethery DE, Kern EF, et al. Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2. J Appl Physiol 2007; 103: 2077-2083.
17. Paine R 3rd, Standiford TJ, Dechert RE, et al. A randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor for patients with acute lung injury. Crit Care Med 2012; 40: 90-97.
18. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definition, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
19. Bierman A, Yerrapureddy A, Reddy NM, et al. Epidermal growth factor receptor (EGFR) regulates mechanical ventilation-induced lung injury in mice. Transl Res 2008; 152: 265-272.
20. Harada C, Kawaguchi T, Ogata-Suetsugu S, et al. EGFR tyrosine kinase inhibition worsens acute lung injury in mice with repairing airway epithelium. Am J Respir Crit Care Med 2011; 183: 743-510.
21. Schoenfeld DA, Bernard GR. Statistical evaluation of ventilatorfree days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30: 1772-1777.
22. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
23. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-2575.
24. van der Schaaf M, Beelen A, Dongelmans DA, et al. Poor functional recovery after a critical illness: A longitudinal study. J Rehabil Med 2009; 41: 1041-1048.
25. Herridge MS, Cheung AM, Tansey CM, et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-693.
26. Schelling G, Stoll C, Vogelmeier C, et al. Pulmonary function and health-related quality of life in a sample of long-term survivors of the acute respiratory distress syndrome. Intensive Care Med 2000; 26: 1304-1311.
27. Ware LB, Koyama T, Billheimer DD, et al. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010; 137: 288-296.
28. Calfee CS, Ware LB, Glidden DV, et al. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 2011; 39: 711-717.
29. Ware LB. Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 2005; 33: S217-S222.
30. Raymondos K, Martin MU, Schmudlach T, et al. Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma. Injury 2012; 43: 189-195.
31. Gharib SA, Liles WC, Klaff LS, et al. Noninjurious mechanical ventilation activates a proinflammatory transcriptional program in the lung. Physiol Genomics 2009; 37: 239-248.
32. Stern JB, Fierobe L, Paugam C, et al. Keratinocyte growth factor and hepatocyte growth factor in bronchoalveolar lavage fluid in acute respiratory distress syndrome patients. Crit Care Med 2000; 28: 2326-2333.
33. Miyazaki E, Nureki S, Ono E, et al. Circulating thymus-and activation-regulated chemokine/CCL17 is a useful biomarker for discriminating acute eosinophilic pneumonia from other causes of acute lung injury. Chest 2007; 131: 1726-1734.
34. Ranieri VM, Suter PM, Tortorella C, et al. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: A randomized controlled trial. JAMA 1999; 282: 54-61.
35. Checkley W, Brower RG, Munoz A. Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology 2010; 21: 557-565.